Egfr Mutations | sciencenewsnet.in

Breaking News

Novel material supercharges innovation in electrostatic energy storage

A Common Pathway in the Brain That Enables Addictive Drugs to Hijack Natural Reward Processing Has Been Identified by Mount Sinai

MSU expert to attend oral arguments in SCOTUS case that could turn homelessness into a crime

New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies

Dana-Farber Chief Scientific Officer, Kevin Haigis, PhD, elected as Fellow of the American Association for the Advancement of Science

Hubble Goes Hunting for Small Main Belt Asteroids

Two U Professors Selected as AAAS Fellows

New research finds electric vehicles depreciate faster than gas cars, but the trend is changing

Moffitt Researchers Discover New Therapeutic Target for Non-Small Cell Lung Cancer

UIowa finance expert says AI will only slowly affect hiring on Wall Street

18 Apr, 2024

MD Anderson EGFR Classification licensed by BostonGene and Tempus to provide new insight on atypical mutations in lung cancer

January 19, 2023 sarah JonasAnnouncement

MD Anderson announced licensing agreements with BostonGene and Tempus for the MD Anderson EGFR Classification, which organizes EGFR mutations into subgroups that may guide clinical decision-making.

Study Reinforces Benefit Using Targeted Therapy for Early Stage NSCLC

September 21, 2020 sarah JonasResearch Results

According to updated findings led by researchers at Yale Cancer Center, treatment with the targeted therapy osimertinib following surgery continues to significantly improve disease-free survival (DFS) in patients with early-stage, non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) gene mutations.